Money · Lobbying reports · 119th Congress
H.R. 3521
19 saved lobbying reports name H.R. 3521.
19 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read October 7, 2026 at 6:29 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Report |
|---|---|---|---|---|
| ASSOCIATION FOR CLINICAL ONCOLOGY | ASSOCIATION FOR CLINICAL ONCOLOGY | $480,000.00reported as expenses | April to June 2026 | Open the report |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | $890,000.00reported as expenses | April to June 2026 | Open the report |
| NORTH SOUTH GOVERNMENT STRATEGIES F/K/A JDM PUBLIC STRATEGIES, LLC | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER | $30,000.00reported as income | April to June 2026 | Open the report |
| SMITHBUCKLIN CORPORATION | ASTCT | $70,000.00reported as income | April to June 2026 | Open the report |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. | AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC | $1,240,000.00reported as expenses | April to June 2026 | Open the report |
| AMERICAN LUNG ASSOCIATION | AMERICAN LUNG ASSOCIATION | $120,000.00reported as expenses | April to June 2026 | Open the report |
| ASTRAZENECA PHARMACEUTICALS LP | ASTRAZENECA PHARMACEUTICALS LP | $1,680,000.00reported as expenses | April to June 2026 | Open the report |
| ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS) | ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS) | $10,000.00reported as expenses | April to June 2026 | Open the report |
| WILLIAMS AND JENSEN, PLLC | AMERICAN CANCER SOCIETY ACTION NETWORK, INC. | $50,000.00reported as income | April to June 2026 | Open the report |
| MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) | MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS | $530,000.00reported as expenses | April to June 2026 | Open the report |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $7,360,000.00reported as expenses | April to June 2026 | Open the report |
| JOHNSON & JOHNSON SERVICES, INC. | JOHNSON & JOHNSON SERVICES INC | $1,440,000.00reported as expenses | April to June 2026 | Open the report |
| BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | $590,000.00reported as expenses | April to June 2026 | Open the report |
| VENABLE LLP | PATIENT ACCESS NETWORK FOUNDATION | $40,000.00reported as income | April to June 2026 | Open the report |
| THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN | THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN | $130,000.00reported as expenses | April to June 2026 | Open the report |
| NATIONAL HEALTH COUNCIL | NATIONAL HEALTH COUNCIL | $25,779.00reported as expenses | April to June 2026 | Open the report |
| MGD STRATEGIES LLC | ESOPHAGEAL CANCER ACTION NETWORK (ECAN) | $20,000.00reported as income | April to June 2026 | Open the report |
| MGD STRATEGIES LLC | CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION | $15,000.00reported as income | April to June 2026 | Open the report |
| MGD STRATEGIES LLC | NATIONAL BRAIN TUMOR SOCIETY ON BEHALF OF DEADLIEST CANCERS COALITION | The report gives no amount | April to June 2026 | Open the report |